| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |